X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs BIOCON LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD BIOCON LTD MERCK LTD/
BIOCON LTD
 
P/E (TTM) x 45.1 49.9 90.5% View Chart
P/BV x 6.6 7.3 90.6% View Chart
Dividend Yield % 0.5 0.2 323.8%  

Financials

 MERCK LTD   BIOCON LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-17
BIOCON LTD
Mar-18
MERCK LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,3581,188 114.3%   
Low Rs933305 305.9%   
Sales per share (Unadj.) Rs665.068.7 967.7%  
Earnings per share (Unadj.) Rs56.67.6 749.1%  
Cash flow per share (Unadj.) Rs72.514.0 518.8%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %1.30.1 977.7%  
Book value per share (Unadj.) Rs441.786.3 511.6%  
Shares outstanding (eoy) m16.60600.00 2.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.710.9 15.9%   
Avg P/E ratio x20.298.9 20.5%  
P/CF ratio (eoy) x15.853.4 29.6%  
Price / Book Value ratio x2.68.6 30.0%  
Dividend payout %26.513.2 200.2%   
Avg Mkt Cap Rs m19,011447,900 4.2%   
No. of employees `0001.56.1 25.1%   
Total wages/salary Rs m1,6969,311 18.2%   
Avg. sales/employee Rs Th7,150.06,705.8 106.6%   
Avg. wages/employee Rs Th1,098.71,514.2 72.6%   
Avg. net profit/employee Rs Th608.2736.9 82.5%   
INCOME DATA
Net Sales Rs m11,04041,234 26.8%  
Other income Rs m2402,062 11.6%   
Total revenues Rs m11,27943,296 26.1%   
Gross profit Rs m1,3768,291 16.6%  
Depreciation Rs m2643,851 6.9%   
Interest Rs m0615 0.0%   
Profit before tax Rs m1,3525,887 23.0%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5831,569 37.1%   
Profit after tax Rs m9394,531 20.7%  
Gross profit margin %12.520.1 62.0%  
Effective tax rate %43.126.7 161.8%   
Net profit margin %8.511.0 77.4%  
BALANCE SHEET DATA
Current assets Rs m7,52341,486 18.1%   
Current liabilities Rs m2,25321,413 10.5%   
Net working cap to sales %47.748.7 98.1%  
Current ratio x3.31.9 172.4%  
Inventory Days Days5264 81.5%  
Debtors Days Days4194 43.1%  
Net fixed assets Rs m1,24050,661 2.4%   
Share capital Rs m1663,000 5.5%   
"Free" reserves Rs m7,16748,808 14.7%   
Net worth Rs m7,33351,808 14.2%   
Long term debt Rs m017,898 0.0%   
Total assets Rs m9,91299,897 9.9%  
Interest coverage xNM10.6-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.10.4 269.8%   
Return on assets %9.55.2 183.9%  
Return on equity %12.88.7 146.4%  
Return on capital %20.89.6 215.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01512,058 8.4%   
Fx outflow Rs m3,0437,348 41.4%   
Net fx Rs m-2,0284,710 -43.1%   
CASH FLOW
From Operations Rs m5376,621 8.1%  
From Investments Rs m-476-6,840 7.0%  
From Financial Activity Rs m-220-2,397 9.2%  
Net Cashflow Rs m-160-2,612 6.1%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.8 20.6 251.5%  
Indian inst/Mut Fund % 18.2 8.4 216.7%  
FIIs % 1.0 10.7 9.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 19.9 146.2%  
Shareholders   28,591 109,995 26.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 260 Points Down; TCS & Infosys Top Losers(12:30 pm)

Stock markets in India are presently trading lower, tracking weakness in their global peers. Among the sectoral indices, IT stocks and metal stocks are witnessing maximum selling pressure.

Related Views on News

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Nov 21, 2018 02:57 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS